Loading clinical trials...
Loading clinical trials...
89Zr-AMG211 PET Imaging in Patients With Relapsed/Refractory Gastrointestinal Adenocarcinoma Before and During Treatment With AMG 211
Conditions
Interventions
89Zr-AMG211
89-ZrAMG211 PET
Locations
2
Netherlands
VUmc
Amsterdam, Netherlands
University Medical Center Groningen
Groningen, Netherlands
Start Date
August 1, 2016
Primary Completion Date
May 3, 2017
Completion Date
May 3, 2017
Last Updated
May 3, 2024
Lead Sponsor
University Medical Center Groningen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions